baber/WOPTO huggingface dataset:
Patent AT-E417655-T1 (AT)
Inventor: SCHIELE STEFAN
IPC: A63C5/02
Filed: 1997-10-23
Granted: 2009-01-15
Abstract: A snowboard, in particular for tour snowboarding outside of prepared tracks, consists of several individual bodies (6, 7, 8, 9) of which two sliding bodies (6, 9) which can be used as skis or as ascension aids. The snowboard has a combined binding and joining system for joining the various individual bodies.
Patent AT-E239505-T1 (AT)
Inventor: SAWA SHIROU
IPC: A61K9/00
Filed: 1998-02-03
Granted: 2003-05-15
Abstract: A method for solubilizing a pyridonecarboxylic acid or a pharmacologically acceptable salt thereof, which comprises adding an arylcarboxylic acid of the formula (I): L<1> -R<1> COOH wherein L<1> is an optionally substituted heterocyclic group or aryl group having not more than 14 carbon atoms, and R<1> is an optionally substituted alkyl group having not more than 4 carbon atoms or a single bond, to the pyridonecarboxylic acid or the pharmacologically acceptable salt thereof, a solubilizer thereof and an aqueous solution containing a solubilized pyridonecarboxylic acid. According to the solubilization method of the present invention, the solubility of pyridonecarboxylic acid compounds and salts thereof at near physiological pH can be increased, thereby making the production of an aqueous solution to be used as an eye drop, nasal drop, ear drop and the like possible.
Patent AT-E229323-T1 (AT)
Inventor: BJOERKMAN SVEN DR
IPC: A61K9/08
Filed: 1998-09-18
Granted: 2002-12-15
Abstract: Stable, aqueous form of (+)-(R)-thalidomide or (-)-(S)-thalidomide contains the enantiomer of thalidomide dissolved in pure form in isotonic glucose solution and has a pH ≤ 5.5. An Independent claim is also included for the production of the aqueous thalidomide solution, comprising: (a) adding (+)-(R) or (-)-S-thalidomide to isotonic glucose at pH 4-5; (b) shaking until dissolution is complete; and (c) treating with ultrasound and filtering under aseptic conditions. Use of pure enantiomers of thalidomide allows water-stable solutions that do not give rise to toxicological effects. The enantiomers have higher solubility in water than the racemate. At pH ≤ 5.5, hydrolysis of thalidomide does not occur. Solutions are suitable for parenteral administration.
Patent AT-E201181-T1 (AT)
Inventor: PRINZ GUENTHER
IPC: B65G51/32
Filed: 1998-11-13
Granted: 2001-06-15
Abstract: The tube post station (1) includes a transfer tube (7) and a bush lift. The transfer tube is displaced and the bush lift is moved up and down by a single drive (9). A turning lever (10) is fitted roughly parallel to the displacement plane (8) of the transfer tube (7). The lever grips non-positively under the bush lift. There is a carrier (18) in the lifting direction (15) of the bush lift on the transfer tube, passing through open rocker arms (19) at each end.
Patent AT-E242371-T1 (AT)
Inventor: HEIERLI MARCEL
IPC: E03D1/14
Filed: 1998-11-16
Granted: 2003-06-15
Abstract: Two buttons (4,5) are provided in a housing (2) and cooperate with a pressure pulse transducer (6), which is configured so that pressing one or the other button produces two different pressure pulses. The pressure pulse transducer is preferably in the form of two bellows, one assigned to each button, which are rectangular in cross section, having narrow sides half the width of the broad sides.
Patent AT-E283914-T1 (AT)
Inventor: ACHTMAN MARK
IPC: A61K39/095
Filed: 1998-01-20
Granted: 2004-12-15
Abstract: The present invention is concerned with a fragment of IgA1-protease having 40 to 200 amino acid residues and comprising at least 40 amino acids of an amino acid sequence as shown in SEQ ID NO:1, beginning with the amino acid in any one of positions 1 to 5 and ending with an amino acid in any one of positions 40 to 104 or a homologous sequence, its use as a carrier for a conjugate, particularly in combination with a polysaccharide, and a process for producing the peptide as well as vaccines comprising said peptide.
Patent AT-E222748-T1 (AT)
Inventor: MIRAJKAR YELLOJI RAO K
IPC: A61K8/34
Filed: 1998-02-10
Granted: 2002-09-15
Abstract: An oral composition and method for use thereof, comprising in an orally acceptable vehicle, an effective antiplaque amount of a noncationic antibacterial agent, and an anionic copolymer formed from monomers of which about 40 to about 90% by weight are hydrophilic type capable of attachment to oral surfaces and about 10 to about 60% by weight are of a hydrophobic type; such oral composition being effective in increasing the uptake of the antibacterial compound to dental tissue so as to enhance the therapeutic efficacy of the administered antibacterial compound.
Patent AT-E263268-T1 (AT)
Inventor: EVANS TIMOTHY D
IPC: D21C9/10
Filed: 1998-05-15
Granted: 2004-04-15
Abstract: A composition and method for use in the peroxide, oxygen, or peroxide/oxygen stage of brightening pulps with less than 18 % lignin utilize a megnesium compound in a sodium silicate solution to form a higher percentage of high molecular weight silicates. Such high molecular weight silicates preferentially adsorb transition metal impurities which, if left in solution, would tend to decompose hydrogen peroxide and organic peroxides. Hydrogen peroxide is added to peroxide and peroxide/oxygen stages, while it is generated, along with organic peroxides, during an oxygen stage. Decomposition decreases the amount of peroxide that actually reacts with lignin and generates free radicals that attack the desired product, carbohydrate fibers. The high molecular weight silicates can be formed by using any magnesium compound which dissociates to form Mg(OH)<+> cations, which in turn cause a silicate polymerization reaction. The formation of Mg(OH)<+> cations from magnesium compounds occurs most realidy over a pH range of at least about 8 and preferably between about 8 and about 12. The magnesium compound is added in an amount to achieve an Mg:SiO2 mass ratio of between about 1:46 to about 1:2, and preferably between about 1:15 to about 1:3.
Patent AT-E382721-T1 (AT)
Inventor: IKEDA JIRO
IPC: G11B5/85
Filed: 1998-07-17
Granted: 2008-01-15
Abstract: The purpose of this invention is to provide a magnetron sputtering apparatus capable of attaching masks on disk substrates and capable of conducting sputtering while disk substrates are being rotated on the central axis without complicated mechanisms or complicated processes. For this purpose, in the sputtering apparatus of this invention, a magnetic field generating means is provided above the sputtering chamber so as to apply magnetic field in the sputtering chamber 11 providing discharge space. A target 21 is arranged at the upper portion of this sputtering chamber 11 so that the magnetic field by said magnetic field generating means is applied. A disk transport chamber is provided which is connected to said sputtering chamber 11 through the opening 32 formed on the bottom wall 30. In this disk transport chamber 12, a disk pusher 34 is provided which places thereon the disk substrate 31 for depositing sputter film, transports to the opening 32 of said sputtering chamber 11 and rotates said disk substrate 31 on the plane of said disk pusher. In the sputtering chamber 11, a rotation center mask 27 is provided which makes contact with the upper center portion of said disk substrate 31 placed on said disk pusher 34, and rotates with the rotation of said disk substrate 31. <IMAGE>
Patent AT-E230064-T1 (AT)
Inventor: ADACHI JUNN
IPC: E21D11/38
Filed: 1998-06-13
Granted: 2003-01-15
Abstract: A sealing arrangement (1) has two abutting construction elements made of concrete, steel, reinforced concrete, cast iron or other materials, as well as a sealing section made of an elastomer material which sealingly bridges the gap between the two construction elements. The construction elements are in particular segments (2, 2'') which are assembled into a tubular tunnel with transverse and longitudinal joints (3). Each segment is preferably provided with a continuous groove on all its abutting sides. An elongated sealing profile (5) is located in each groove, forming a sealing frame with frame corners. The sealing section has elongated open and/or closed flutes arranged on the section base side and elongated ducts arranged between the flutes and the section front side. The sealing section (5) also has at least two groups (A, B) of ducts of which the first (A) is located directly above the flutes while the other (B) is laterally offset with respect to the flutes. Both groups (A, B) of ducts lie substantially in a plane parallel to the base or front side of the section.
Patent AT-E219413-T1 (AT)
Inventor: LOWEMARK BENGT
IPC: B25B27/24
Filed: 1998-09-09
Granted: 2002-07-15
Abstract: A tool for mounting of disk valves in motor cylinder heads includes a shaft and a spring-loaded tap that may be pressed into the shaft, and two vaulted clamping arms placed on opposite sides of the shaft, with the purpose of holding two locking bodies in connection with the occasion when these bodies are to be transferred to the rod of the valve. On the individual clamping arm there are protrusions that protrude relative to an axially straight inside on the clamping arm and serve as carriers for the individual locking body. Each protrusion has support surfaces that are obliquely positioned relative to the clamping arm in order to hold a convexly vaulted outside on the locking body placed against the concave inside of the clamping arm, when the locking body is dislocated from the tap to grooves in the valve rod, thereby distancing the front edge of the locking body from the external envelope surface of the valve rod.
Patent AT-E381533-T1 (AT)
Inventor: DURANT GRAHAM
IPC: C07D243/12
Filed: 1998-10-20
Granted: 2008-01-15
Abstract: The present invention relates to pharmaceutically acceptable compounds, including acylguanidine compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for the treatment or prophylaxis of neurological injury and neurodegenerative disorders.
Patent AT-E251541-T1 (AT)
Inventor: REES HERBERT
IPC: B29C35/08
Filed: 1999-01-14
Granted: 2003-10-15
Abstract: A compression mold (10) and blow mold (12) are provided in spaced relationship to each other. A preform (18) is formed from a preform precursor (16) in the compression mold (10) and transferred to a blow mold (12) while maintaining the spaced relationship between the compression mold (10) and blow mold (12), and a container (32) is formed from the preform (18) in the blow mold (12). <IMAGE>
Patent AT-E280798-T1 (AT)
Inventor: CHANG YOUNG BAE
IPC: C08F12/08
Filed: 1999-03-29
Granted: 2004-11-15
Abstract: A process for producing foamed styrene resin bead, which comprises the steps of:   (a) the first polymerization step in which 10 to 30wt% of pre-mixture comprising styrene monomer, crosslinking agent, chain transfer agent, initiator and surface active agent, 0.5 to 6.0wt% of dispersion master comprising pure water and dispersing agent, 50 to 55wt% of hot pure water and 1 to 15wt% of styrene monomer are mixed in the reactor at 50 to 70 DEG C and then the reactor is heated to the temperature range of 80 to 100 DEG C; (b) the second polymerization step in which, at the conversion rate of 5 to 15%, 5 to 25wt% of the pre-mixture, 1 to 15wt% of styrene monomer, 0.05 to 1.0wt% of cell controller and 0.5 to 6.0wt% of dispersion master are further added to the reactor and then polymerized; (c) the third polymerization step in which, at the conversion rate of 50 to 70%, 0.05 to 1.0wt% of cell controller and 0.5 to 6.0wt% of dispersion master are still further added to the reactor and then polymerized; (d) the fourth polymerization step in which, at the conversion rate of 80 to 90%, 0.5 to 6.0wt% of dispersion master is further added to the reactor and then polymerized; and (e) the step in which the reactor is heated to temperature of 110 to 135 DEG C and at the conversion rate of 85 to 95%, the flame retardant, inert gas and foaming agent are added.
Patent AT-E229936-T1 (AT)
Inventor: SABATER-LUENTZEL CHRISTOPHER D
IPC: A23L27/20
Filed: 1999-08-02
Granted: 2003-01-15
Abstract: Described are compounds of the general formula AwhereR2=CH3, C2H5, C3H7 (n, iso) or C4H9 (n, iso, tert) andR2=CH3, C2H5, C3H7 (n, iso) or C4H9 (n, iso, tert)which are especially useful as fragrance or flavor materials. The 3-mercapto-2-alkyl-alkanals of the general formula A in which X-CHO are formed by reaction of the corresponding 2-alkyl-2-alkenals with hydrogen sulfide.
Patent AT-E251962-T1 (AT)
Inventor: FISH JOHN ANDREW
IPC: B22D11/06
Filed: 1999-05-14
Granted: 2003-11-15
Abstract: Twin roll strip casting apparatus in which a pair of pool confining side plates (56) engage end surfaces of casting rolls (16) to form side confining closures for the pool. Plates (56) are mounted in side plate holders (82) connected to horizontally acting thrusters (83) which apply inward closure forces to the side plates (56). Thrusters (83) are mounted on a pair of carriages (101) disposed one at each end of the casting roll assembly and moveable toward and away from one another to enable the spacing between them to be adjusted so that the carriages (101) can be preset before a casting operation to suit the width of the casting rolls (16). Carriages (101) are mounted on a central frame structure (103) which sits over the casting rolls (16).
Patent AT-E218249-T1 (AT)
Inventor: OESTERHELD JOERG DR
IPC: B32B1/08
Filed: 1999-12-09
Granted: 2002-06-15
Abstract: The hose has a glass fibre bundle (1), a tightly woven, inner glass fibre hose (2) enveloping the bundle, a flexible polymer coating (3) with rubber-elastic properties on the hose and a tightly woven outer glass fibre hose (4) enclosing the polymer coating.  An Independent claim is also included for a method of manufacturing a strengthened, pressure-tight hose.
Patent AT-E350867-T1 (AT)
Inventor: HAARTSEN JACOBUS
IPC: H04B1/713
Filed: 1999-04-01
Granted: 2007-01-15
Abstract: An uncoordinated frequency hopping cellular system includes a mobile unit and a number of base stations. The mobile unit determines which base stations are in a geographical location defined by a location of the mobile unit. This determination is made by transmitting one or more inquiry messages, and receiving response information transmitted by responding base stations. The mobile unit then selects, for use by the mobile unit, one of the base stations from the set of base stations. Each of the base stations receives at least one of the inquiry messages, and transmits the response information to the mobile unit in response to the at least one received inquiry message. The mobile unit determines synchronization information from the response information, and uses this to establish communication with the selected base station.
Patent AT-E349946-T1 (AT)
Inventor: CHARASH DAN
IPC: A61B5/145
Filed: 1999-05-28
Granted: 2007-01-15
Abstract: The fundamental frequency of EIG events is determined directly, without first detecting the events themselves. Use is made of an analysis window containing more than one event (3-5). Techniques (1-8) are utilized which are somewhat similar to those utilized to detect, and estimate pitch in speech processing. The invention is based on two important biological discoveries. The first is that the EIG is generated by a functional pace maker. The second is that the EIG signal is quasi-periodic most of the time. The use of pitch detection algorithms is based on the essentially quasi-periodic nature of the EIG signal. Quasi-periodic means that the intervals between successive events are not exactly identical, but may vary slightly, that the amplitude and shape of successive events may also exhibit some variance.
Patent AT-E227294-T1 (AT)
Inventor: DIVE VINCENT
IPC: A61K38/00
Filed: 1999-07-01
Granted: 2002-11-15
Abstract: The invention relates to peptide derivatives that can be used as selective inhibitors of the N-terminal site of human angiotensin-converting enzyme.The derivatives comprise the amino acid sequence with the following formula:wherein:Ψ(PO2CH2) indicates that the peptide bond (CONH) between Phe and Ala has been replaced by the phosphonic bond PO2CH2, andXaa' represents an amino acid residue.They can be used in pharmaceutical formulations, particularly to protect haematopoietic strain cells of patients undergoing aggressive chemotherapy or radiotherapy treatment.
Patent AT-E246256-T1 (AT)
Inventor: NARDONE GLENN
IPC: C12N15/09
Filed: 1999-06-11
Granted: 2003-08-15
Abstract: An oligonucleotide, labeled with a molecular energy transfer trio and containing two sequences capable of hairpin formation, is used in the detection of two targets by irradiation with a single wavelength of light. One of the two sequences contains an energy donor and a first energy acceptor, and the other sequence contains a second energy acceptor. The donor is in close proximity to the second acceptor only if the hairpin is formed, while the donor is always in close proximity to first acceptor. A sample is assayed, using this oligonucleotide in conjunction with another oligonucleotide which contains the donor fluorophore and the quencher, arranged as described above, but which lacks the acceptor fluorophore. The present oligonucleotide and the other oligonucleotide are specific to first and second targets, respectively. If a sample contains the first and second targets, then hairpin formation is prevented after each oligonucleotide is incorporated into a target amplification product or hybridized to a target. Subsequent irradiation of the sample with the single wavelength of light which excites the donor fluorophore, but not the acceptor fluorophore, causes two distinctive signals to be generated. The first signal is emitted by the second fluorophore of the present oligonucleotide, while the second signal is emitted by the first fluorophore of the other oligonucleotide. Thus, the first and second targets are detected when one observes the first and second signals, respectively.
Patent AT-E236927-T1 (AT)
Inventor: KOBAYASHI EIJI
IPC: A61K38/00
Filed: 1999-08-10
Granted: 2003-04-15
Abstract: 5-Membered ring compounds represented by general formula (I), optically active isomers thereof or salts of the same. These compounds have physiological activities including a carcinostatic effect. In said formula the bond shown by the dotted line in the 5-membered ring represents that this 5-membered ring may be either a cyclopentene ring having a double bond or a saturated cyclopentane ring, and when the 5-membered ring is a cyclopentene ring, X is OR1, Y is =O and Z is H, and when it is a cyclopentane ring, X is =O, Y is OR2 and Z is OR3, (wherein R1 is R4 or -(CO)-R5; R2 is H, -R6 or -(CO)-R7; and R3 is H, R8 or (CO)-R9 (wherein R4, R5, R6, R7, R8 and R9 are the same or different and each represents an aliphatic, aromatic or aliphatic aromatic group, and R5, R7 and R9 may be each H), provided that the case where R2=R3=H is excluded); and W represents a residue obtained by eliminating SH from an SH-containing compound.
Patent AT-E248799-T1 (AT)
Inventor: OFORI JOHN YAW
IPC: C07C37/72
Filed: 1999-10-01
Granted: 2003-09-15
Abstract: A method for efficiently recovering a hydroxyaromatic compound from aqueous extract streams of diaryl carbonate reaction mixtures, comprises contacting the aqueous extracts with a suitable solvent, preferably diphenyl carbonate or anisole. The aqueous stream may then be further recycled or reclaimed, and the hydroxyaromatic compound isolated from the solvent for disposal or further use.
Patent AT-E296549-T1 (AT)
Inventor: AKRAPOVIC IVAN
IPC: A42B3/06
Filed: 1999-12-29
Granted: 2005-06-15
Abstract: The helmet with spherical vizor solves the technical problem of increasing protective effects of the helmet against mechanical, thermal, light, resounding and chemical effects from the direct environment at performing fire and other activities with simultaneous simplification of construction and reduction of production costs. The Figure shows the helmet consisting of the shell (1), ring support (2), spherical vizor (3), six-arm cross with the head basket, latchets for helmet binding, neck protection piece (4) and connective elements. The ring support (2) is with screws (25) and joints with axes (O) round which the spherical vizor (3) is rotating, connected to the lower part of the inner jacket of the shell (1). All connections of arms of the six-arm cross, latchets for binding and the neck protection piece (4) are made on the inner jacket of the ring support (2). By binding these parts to the simple ring support (2), the manufacture is simplified and the manufacture costs reduces and mechanical resistance of the helmet is increased. The spherical form of the vizor (3) with reinforced outside and inner edge enables the use of that helmet in combination with masks for protection of respiratory organs.
Patent AT-E250280-T1 (AT)
Inventor: GEENS RUDY E A
IPC: H01J61/22
Filed: 1999-10-29
Granted: 2003-10-15
Abstract: A high pressure sodium vapour lamp having a fill consisting of sodium, mercury and xenon in an arc tube with a sodium weight portion within the sodium-mercury-amalgam of approx. 12% to approx. 20%, having a xenon filling pressure in the cold state between approx. 180 Torr and approx. 350 Torr, having a D-line reversal width (distance of the tops of both wings of the sodium-D-line of the radiation spectrum) of approx. 110 Å to approx. 200 Å, and having approx. 14% to approx. 18% radiation portion in the red wave length range 635 nm to 750 nm and having approx. 7% to approx. 10% radiation portion in the blue wave length range 380 nm to 500 nm, in each case of the radiation power in the wave length range 380 nm to 780 nm for promotion of plant growth is provided.
Patent DE-1169920-T1 (DE)
Inventor: LEHOUX JANNICK
IPC: A01N25/18
Filed: 2001-07-02
Abstract: A process for the elimination of insects and arachnids, especially acarids, comprises diffusing a solution of permethrin and tetramethrin, optionally with piperonyl butoxide, in a combustible solvent using a catalytic combustion means. The diffusion is affected using an apparatus as shown in the drawing. Solution (4) of permethrin and tetramethrin in a combustible solvent diffuses up wick (8) to a catalytic combustion means (14).
Patent DE-06008391-T1 (DE)
Title: Hybrid-Turbomolekularvakuumpumpe
Inventor: HABLANIAN MARSBED
IPC: F04D23/00
Filed: 2006-04-24
Abstract: Vakuumpumpe,
die aufweist:  ein Gehäuse
mit einer Einlassöffnung
und einer Auslassöffnung;  eine
oder mehrere innerhalb des Gehäuses
angeordnete Axialströmungsstufen,
wobei jede der Axialströmungsstufen
einen Stator und ein Laufrad umfasst, die jeweils geneigte Schaufeln
aufweisen;  zumindest eine zusätzliche Vakuumpumpstufe, die
keine Axialströmungsstufe
ist, wobei die zusätzliche
Vakuumpumpstufe innerhalb des Gehäuses angeordnet ist und einen
Stator und ein Laufrad umfasst; und  einen Motor zum Drehen
der Laufräder,
so dass Gas von der Einlassöffnung
zur Auslassöffnung
gepumpt wird, wobei die Vakuumpumpe keine Molekular-Drag-Stufe mit
einer rotierenden, zylinderförmigen
Trommel oder einer rotierenden Scheibe mit einer flachen Pumpfläche aufweist.
Patent DE-588813-T1 (DE)
Inventor: SYSLAK MORTEN
IPC: B23K1/20
Filed: 1992-05-13
Abstract: Al components are brazed together by a) coating at least one of the components with a layer of Zn (based alloy) and coating with b) an assembly the components as required. c) heating the assembly to a predetermined temp. and for a predetermined time, so that a filter metal layer is formed between the components by diffusion of Zn from the surface layer into the components and melting of the interface Zn-Al alloys formed. d) cooling the assembly to form solidified joints between the components.